![]() ![]() Weight, height, and waist circumference were measured and body mass index (BMI) was calculated. In all study subjects, an interviewer-administered questionnaire was used to obtain demographic, behavioral and medical information. ![]() A total of 16,607 individuals (5,112 urban and 11,495 rural) were selected from 363 PSUs (188 urban and 175 rural), of whom, 14,277 individuals responded (response rate 86%). ![]() In both urban and rural areas, one individual was chosen from the selected household following the World Health Organization (WHO) KISH method. Thus, the sample size for the entire study once completed would be 1,24,000 (28 states, 2 UTs and 1 NCT) and the sample size for the Phase I of the study was estimated to be 16,000 individuals. Using a precision of 20% (80% power) and allowing for a non-response rate of 20%, the sample size was calculated to be 4,000 per state/UT (2,800 rural and 1,200 urban). A three-level stratification process was done using geography, population size and socio-economic status. The Primary Sampling Units (PSUs) were villages in rural areas and Census Enumeration Blocks (CEBs) in urban areas. In all phases, a stratified multistage sampling design was followed. This paper presents results of Phase I of the study. In INDIAB-NE, the 8 north eastern states namely Sikkim, Assam, Meghalaya, Tripura, Mizoram, Manipur, Nagaland and Arunachal Pradesh are being sampled and in phase II, 5 other states from the rest of India are currently in progress. These four states have a population of 213 million, which is roughly 1/8 of India's total population of 1.2 billion people. ![]() Phase I of the ICMR-INDIAB study was conducted from November 2008 to April 2010, and included three states randomly selected to represent the south (Tamilnadu), west (Maharashtra), and east (Jharkhand) of India and one union territory (UT) representing northern India (Chandigarh). The study plans to survey all the 28 states in India, the two Union Territories (UT) of Chandigarh and Puducherry and the National Capital Territory (NCT) of Delhi in a phased manner. Briefly, this is a cross-sectional survey involving adults aged 20 years and above (age range: 20–90 years). The methodology of the ICMR-INDIAB study has been published separately. This article will report on the lipid patterns and prevalence of lipid abnormalities of the Indian population studied in Phase I of the Indian Council of Medical Research India Diabetes Study (ICMR-INDIAB study), involving three states and one union territory (UT), representing the north, south, east and west of the country. The estimation of the prevalence of dyslipidemia will ensure proper planning of health care resources for both primary and secondary prevention of CVDs. While Asian Indians are known to have a unique pattern of dyslipidemia with lower HDL cholesterol, increased triglyceride levels and higher proportion of small dense LDL cholesterol, there have been no large scale representative studies on dyslipidemia to assess the magnitude of the problem in India. Dyslipidemia has been closely linked to the pathophysiology of CVD and is a key independent modifiable risk factor for cardiovascular disease. The likely causes for the increase in the CVD rates include lifestyle changes associated with urbanization and the epidemiologic and nutritional transitions that accompany economic development. Asian Indians have been found to develop CVD at a younger age than other populations. In India, there has been an alarming increase in the prevalence of CVD over the past two decades so much so that accounts for 24% of all deaths among adults aged 25–69 years. The funders, Indian Council of Medical Research, provided expertise in designing the study and revising the manuscript critically for important intellectual content.Ĭompeting interests: The authors have declared that no competing interests exist.Ĭardiovascular disease (CVD) is the leading cause of death worldwide, and mortality due to CVD is higher in low- and middle-income countries. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.įunding: This study was funded by the Indian Council of Medical Research, New Delhi (No. Received: JanuAccepted: ApPublished: May 9, 2014Ĭopyright: © 2014 Joshi et al. PLoS ONE 9(5):Įditor: Kashish Goel, Mayo Clinic, United States of America (2014) Prevalence of Dyslipidemia in Urban and Rural India: The ICMR–INDIAB Study. Citation: Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK, et al. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |